Table 3.

Secondary outcomes

Outcome	Ramipril (N = 79)	Placebo (N = 35)
Continued hospitalization at day 14, n (%)	1 (1)	0 (0)
Time to discharge, days (SD)	3 (3)	3 (3)
Need for hospitalization among outpatient participants, n (%)	0 (0)	0 (0)
Hypotension requiring vasopressor support, n (%)	1 (1)	0 (0)
Septic shock, n (%)	2 (3)	0 (0)
Acute kidney injury, n (%)	1 (1)	0 (0)
Mortality or need for intensive care unit (ICU) admission or invasive mechanical ventilator use within 28 days, n (%)	2 (3)	0 (0)